Federal Register / Vol. 60, No. 77 / Friday, April 21, 1995 / Notices 19951

administrative proceedings, including

presentations by participants.

Meetings of advisory committees shall

be conducted, insofar as is practical, in

accordance with the agenda published

in this Federal Register notice. Changes

in the agenda will be announced at the

beginning of the open portion of a

meeting.

Any interested person who wishes to

be assured of the right to make an oral

presentation at the open public hearing

portion of a meeting shall inform the

contact person listed above, either orally

or in writing, prior to the meeting. Any

person attending the hearing who does

not in advance of the meeting request an

opportunity to speak will be allowed to

make an oral presentation at the

hearing’s conclusion, if time permits, at

the chairperson’s discretion.

The agenda, the questions to be

addressed by the committee, and a

current list of committee members will

be available at the meeting location on

the day of the meeting.

Transcripts of the open portion of the

meeting may be requested in writing

from the Freedom of Information Office

(HFI–35), Food and Drug

Administration, rm. 12A–16, 5600

Fishers Lane, Rockville, MD 20857,

approximately 15 working days after the

meeting, at a cost of 10 cents per page.

The transcript may be viewed at the

Dockets Management Branch (HFA–

305), Food and Drug Administration,

rm. 1–23, 12420 Parklawn Dr.,

Rockville, MD 20857, approximately 15

working days after the meeting, between

the hours of 9 a.m. and 4 p.m., Monday

through Friday. Summary minutes of

the open portion of the meeting may be

requested in writing from the Freedom

of Information Office (address above)

beginning approximately 90 days after

the meeting.

This notice is issued under section

10(a)(1) and (2) of the Federal Advisory

Committee Act (5 U.S.C. app. 2), and

FDA’s regulations (21 CFR part 14) on

advisory committees.

Dated: April 17, 1995.

Linda A. Suydam,

Interim Deputy Commissioner for Operations.

[FR Doc. 95–9889 Filed 4–20–95; 8:45 am]

BILLING CODE 4160–01–F

[Docket No. 93N–0005]

Regulation of Positron Emission

Tomography Radiopharmaceutical

Drug Products; Guidance; Public

Workshop; Correction

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice; correction.

SUMMARY: The Food and Drug

Administration (FDA) is correcting a

notice that appeared in the Federal

Register of February 27, 1995 (60 FR

10594). The document published

guidance on the regulation of positron

emission tomography (PET)

radiopharmaceutical drug products and

announced a public workshop to

facilitate an understanding of regulatory

requirements regarding these products.

The document was published with some

typographical errors. This document

corrects those errors.

FOR FURTHER INFORMATION CONTACT:

LaJuana D. Caldwell, Office of Policy

(HF–27), Food and Drug

Administration, 5600 Fishers Lane,

Rockville, MD 20857, 301–443–2994.

In FR Doc. 95–4691, appearing on

page 10594 in the Federal Register of

February 27, 1995, the following

corrections are made:

1. On page 10594, in the third

column, in the title heading,

‘‘TomographyRadiopharmaceutical’’ is

corrected to read ‘‘Tomography

Radiopharmaceutical’’.

2. On page 10595, in the third

column, in the third full paragraph, in

the 4th line from the bottom,

‘‘§ 1A207.10’’ is corrected to read

‘‘§ 207.10’’.

3. On page 10596, in the first column,

in the first full paragraph, in line 8,

‘‘§ 1A361.1’’ is corrected to read

‘‘§ 361.1’’.

4. On page 10596, in the first column,

in the second paragraph, in lines 4 and

20, ‘‘§ 1A361.1(c)’’ is corrected to read

‘‘§ 361.1(c)’’.

5. On page 10596, in the second

column, in the first full paragraph, in

line 3, ‘‘§ 1A361.1(c)(3)’’ is corrected to

read ‘‘§ 361.1(c)(3)’’.

Dated: April 14, 1995.

William B. Schultz,

Deputy Commissioner for Policy.

[FR Doc. 95–9844 Filed 4–20–95; 8:45 am]

BILLING CODE 4160–01–F

SOCIAL SECURITY ADMINISTRATION

Agency Forms Submitted to the Office

of Management and Budget for

Clearance

Normally on Fridays, the Social

Security Administration publishes a list

of information collection packages that

have been submitted to the Office of

Management and Budget (OMB) for

clearance in compliance with Public

Law 96–511, The Paperwork Reduction

Act. The following clearance packages

have been submitted to OMB since the

last list was published in the Federal

Register on Friday, April 7, 1995.

(Call Reports Clearance Officer on (410) 965–

4142 for copies of package.)

1. Measuring Public Perception of the

Value of Social Security—0960–0551.

The information on these questionnaires

is used by the Social Security

Administration (SSA) to measure public

perception of the value of Social

Security and to determine whether the

Personal Earnings and Benefit Statement

(PEBES) affects public confidence in

Social Security. The control group

respondents are members of the general

public who have not received an SSAinitiated PEBES. The study group

respondents are members of the general

public who have received recently an

SSA-initiated PEBES.

SSA has requested and received

expedited approval for this collection of

information (both the study group

collection instrument and the control

group collection instrument) from OMB

and is, accordingly, publishing in the

Federal Register a copy of each of the

collection instruments (5 CFR

1320.18(g)).

Number of Respondents: 6,000

Frequency of Response: 1

Average Burden Per Response: 15

minutes

Estimated Annual Burden: 1,500 hours

OMB Desk Officer: Laura Oliven

Written comments and

recommendations regarding these

information collections should be sent

directly to the appropriate OMB Desk

Officer designated above at the

following address: Office of

Management and Budget, OIRA, New

Executive Office Building, Room 10230,

Washington, DC 20503.

Dated: April 17, 1995.

Charlotte Whitenight,

Reports Clearance Officer, Social Security

Administration.

Measuring Public Perception of the Value of

Social Security (Control Group)

Your Name lllllllllllllll

Your Social Security Number lll-llllll

1. Are you aware that Social Security pays

benefits (circle all that you are aware of):

a. To you when you retire?

b. To you if you became disabled?

c. To your spouse if you became disabled

or retired?

d. To your young children if you became

disabled or retired?

e. To your widow if you should die?

f. To your young children should you die?

2. How important is it for you to plan

financially for your retirement?

a. Very important

b. Somewhat important